Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 3/20 | 0.57 |
| ▸ | CTSE | P14091 | 2/20 | 0.57 |
| ▸ | PGC | P20142 | 1/20 | 0.57 |
| ▸ | CCR1 | P32246 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.39 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.39 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.39 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.39 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | TACR2 | P21452 | 1/20 | 0.39 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6442765 | 0.94 | CTSD (0.59) | CTSDCTSEPGCCCR1CYP3A4 | |
| SCHEMBL7395469 | 0.91 | CTSD (0.43) | CTSDCTSEPGCCCR1ABCB11 | |
| SCHEMBL6707455 | 0.89 | CTSD (0.57) | CTSDCTSEPGCCCR1CYP3A4 | |
| SCHEMBL6445617 | 0.89 | CTSD (0.57) | CTSDCTSEPGCCCR1CYP3A4 | |
| SCHEMBL6445616 | 0.89 | CTSD (0.57) | CTSDCTSEPGCCCR1CYP3A4 | |
| SCHEMBL6445226 | 0.86 | CTSD (0.48) | CTSDCTSEPGCCCR1CYP3A4 | |
| SCHEMBL6443026 | 0.85 | UGT1A1 (0.47) | CTSDCTSEPGCCCR1CYP3A4 | |
| SCHEMBL6447816 | 0.85 | CTSD (0.49) | CTSDCTSEPGCCCR1CYP3A4 | |
| SCHEMBL7290067 | 0.84 | CTSD (0.49) | CTSDCTSEPGCCCR1CYP3A4 | |
| SCHEMBL7290857 | 0.84 | CTSD (0.48) | CTSDCTSEPGCCCR1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050130941-A1 | Methods of treating alzheimer's disease | PHARMACIA & UPJOHN COMPANY LLC | 2005-06-16 | — | — | US | claimed |
| US-20050130941-A1 | Methods of treating alzheimer's disease | PHARMACIA & UPJOHN COMPANY LLC | 2005-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050130941-A1 | Methods of treating alzheimer's disease | BACE1, PSEN1, BACE2 | CTSD 110/4885CTSE 62/4885PGC 1918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.